Briefing: Who is running Iran? The regime's new strongmen
Strategic angle: In the third week of war, who is leading the country? A veil of mystery surrounds a man who remains out of sight.
Israeli strike kills 12 medics in a clinic in southern Lebanon
An overnight Israeli strike resulted in the deaths of a dozen medical staff in southern Lebanon, escalating tensions in the region.
Briefing: GE HealthCare (GEHC) Receives FDA 510 (k) Clearance for View
Strategic angle: GE HealthCare has secured FDA clearance for its new product, enhancing its market position.
Briefing: Israel and Lebanon are expected to hold direct talks in the coming days
Strategic angle: An overnight Israeli strike in southern Lebanon killed a dozen health workers at a clinic, with health authorities reporting 26 paramedics killed since March 2.
Briefing: Tennessee Pushes English-Only Driver Tests, But Critics Warn Plan Could Backfire
Strategic angle: New legislation in Tennessee would require English-only driving tests but allow limited licenses for those who don’t pass.
Briefing: Enhanced fluorescence technique illuminates rapid, coordinated protein folding
Strategic angle: A team of US researchers has gained new insights into how large protein molecules consistently fold themselves into useful shapes.
Briefing: Brazil's ex-President Bolsonaro is in intensive care with pneumonia, hospital says
Strategic angle: One of Bolsonaro's doctors described the former Brazilian president's medical condition as 'serious.'
Briefing: Europe’s fertility rates keep falling: Which countries have the highest rates and biggest drops?
Strategic angle: Euronews Health examines the decline in fertility rates across Europe and the complex factors contributing to this trend.
Briefing: A lab mistake at Cambridge reveals a powerful new way to modify drug molecules
Strategic angle: Cambridge scientists have discovered a light-powered chemical reaction that allows for safer modifications of complex drug molecules.
Briefing: How STAT would cover ‘The Fugitive’ if its pharma scandal were real
Strategic angle: It's Oscar season, so we're bringing you a special STATus report on how we'd cover the drug scandal in 'The Fugitive' if it were real.
Briefing: Vaccinating bats could be good for people. But how do you vaccinate a bat?
Strategic angle: In a new study, bats lap up vaccine-laced saline or chow down on vaccine-carrying mosquitoes. Will that have any impact on the flying mammal's immune system?
Briefing: Bacterial strain breaks decades-old bottleneck in chemotherapy drug manufacturing
Strategic angle: An international team of researchers has achieved a breakthrough in the production of doxorubicin, a vital chemotherapy agent.
Briefing: As 800,000 flee, half of Lebanon lives in war zones without markets, supplies or healthcare
Strategic angle: Genie Godula welcomes Hassan Al-Sayed from Solidarités International, discussing the humanitarian crisis in Lebanon.
Briefing: Ulta Beauty Price Prediction: Post-Earnings Selloff Creates Entry Opportunity
Strategic angle: Analysts suggest that the recent selloff in Ulta Beauty's stock presents a potential buying opportunity for investors.
Briefing: Who is Pakistan supporting in Iran war?
Strategic angle: Islamabad has so far presented itself as a 'neutral' party in the conflict, condemning the US-Israeli strikes on Iran as well as castigating Tehran for its attacks on Saudi Arabia and other Gulf countries.
Briefing: Trump's Influence on Drug Prices: A Closer Look
Strategic angle: Exploring the ongoing battle over drug pricing and the contrasting approaches of Trump and Biden.
Briefing: Who are the key figures in the sewage crisis, and where are they now?
Strategic angle: With anger stoked by Channel 4’s drama Dirty Business, we look at what has happened to some of the main players.
Briefing: Make next year’s flu shots, says FDA committee
Strategic angle: Vaccine skepticism, FDA-authorized vape flavors, and more health news from Morning Rounds
Poll: Public Worries About Prescription Drug Costs Reach New High
Most Across Political Parties Want Government to Do More to Regulate Prices
Briefing: Trump is getting more credit than Biden for efforts to lower drug prices
Strategic angle: Trump is drawing more attention to his efforts to lower drug prices, like TrumpRx.